Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMB-001 in Moderate-to-Severe Cocaine Use Disorder
NCT04501874Phase 2Completed
- Sponsor
- Embera NeuroTherapeutics
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of metyrapone + oxazepam in cocaine use disorder (CUD), sponsored by Embera NeuroTherapeutics. Started Jul 2020; status: completed.
02
Drugs
metyrapone + oxazepam
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT04501874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501874.